Class IV Antiarrhythmic Agents: New Compounds Using an Old Strategy

E-ISSN： 1873-4286|21|8|977-1010

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.8, 2015-03, pp. : 977-1010

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Benefit-Risk Assessment of Class III Antiarrhythmic Agents

By Brendorp B.

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 847-865

Adis International

Access to resources Recommend Favorite

A benefit–risk assessment of class III antiarrhythmic agents

By Elming Hanne Brendorp Bente Pehrson Steen Pedersen Ole Dyg Køber Lars Torp-Petersen Christian

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 559-577

Informa Healthcare

Access to resources Recommend Favorite

Novel Antiarrhythmic Compounds with Combined Class IB and Class III Mode of Action

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation and atrial flutter

By Pecini Redi Elming Hanne Pedersen Ole Dyg Torp-Pedersen Christian

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 311-322

Informa Healthcare

Access to resources Recommend Favorite

Antiarrhythmic drugs: new agents and evolving concepts

By Nemec Jan Shen Win-Kuang

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 435-453

Informa Healthcare

Access to resources Recommend Favorite